Pharmacokinetics and Safety of the Oral Prostaglandin F2alpha Receptor Antagonist OBE022: A First-In-Human Study in Healthy Post-Menopausal Women | NobleID
v1
Pharmacokinetics and Safety of the Oral Prostaglandin F2alpha Receptor Antagonist OBE022: A First-In-Human Study in Healthy Post-Menopausal Women
Ulrike Lorch, Oliver Pohl, Line Marchand, Jean‐Pierre Gotteland
